{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:20:51Z","timestamp":1795054851462,"version":"4.10.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000308","name":"The British Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000308","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["MR\/S003800\/1"],"award-info":[{"award-number":["MR\/S003800\/1"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asthma exacerbations during pregnancy can adversely affect maternal and foetal health. However, prenatal exposure to asthma medication may itself impact child outcomes. This study aims to determine whether prenatal exposure to asthma medication was associated with a range of neurodevelopmental outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A birth cohort was constructed using linked health and education records of children liveborn in Wales from 2009 to 2016, with up to 12\u00a0years follow-up. Generalized estimating equations with a binomial distribution and logit link function were employed to evaluate special educational need (SEN) and its causes, including autism spectrum disorder (ASD), communication problems, behavioural, emotional, and social difficulties, learning difficulties, physical and medical difficulties, and sensory impairment. Cox proportional hazard models were used to investigate attention deficit hyperactivity disorder (ADHD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 179,024 offspring, 11,991 (6.7%) had mothers with treated asthma, 4927 (2.8%) had mothers with untreated asthma, and 5265 (2.9%) had mothers who took asthma medication without a record of asthma. SEN was recorded in 50,955 (28.5%) children. Risk of overall SEN and ADHD was higher following prenatal exposure to short-acting beta-agonists (SABA) and inhaled corticosteroids (ICS) but also higher in the offspring of mothers with untreated asthma (SEN aOR 1.14, 95% CI 1.07\u20131.23; ADHD aHR 1.70, 95% CI 1.42\u20132.05). ASD was associated with treated, but not untreated, asthma and the association with prenatal medication was specific to SABA as mono- or polytherapy (aOR 1.20, 95% CI 1.05\u20131.37). However, a direct comparison of treated with untreated asthma was not statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The non-specific associations with overall SEN and ADHD are likely to reflect their associations with asthma and confounding by indication\/severity. The associations with ASD may reflect a treatment effect of SABA or confounding by severity. Further studies are needed to confirm or refute the former, to support evidence-based asthma management during pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-04699-x","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:34:03Z","timestamp":1771576443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prenatal exposure to maternal asthma and asthma medication and neurodevelopmental outcomes: a population cohort study of 179,024 children"],"prefix":"10.1186","volume":"24","author":[{"given":"Lama A.","family":"Shakhshir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P.","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logesh R.","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"4699_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bpobgyn.2022.06.005","volume":"85","author":"VE Murphy","year":"2022","unstructured":"Murphy VE. Asthma in pregnancy \u2013 management, maternal co-morbidities, and long-term health. Best Pract Res Clin Obstet Gynaecol. 2022;85:45\u201356. https:\/\/doi.org\/10.1016\/j.bpobgyn.2022.06.005.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"4699_CR2","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2019. Available from: https:\/\/www.ginasthma.org."},{"key":"4699_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaci.2004.10.023","volume":"115","author":"WW Busse","year":"2005","unstructured":"Busse WW. NAEPP expert panel report: managing asthma during pregnancy: recommendations for pharmacologic treatment\u20142004 update. J Allergy Clin Immunol. 2005;115:34\u201346. https:\/\/doi.org\/10.1016\/j.jaci.2004.10.023.","journal-title":"J Allergy Clin Immunol"},{"key":"4699_CR4","doi-asserted-by":"publisher","unstructured":"Popa M, Peltecu G, Gica N, Ciobanu AM, Botezatu R, Gica C, et al. Asthma in Pregnancy. Review of Current Literature and Recommendations. Maedica - J Clin Med. 2021;16. https:\/\/doi.org\/10.26574\/maedica.2021.16.1.80.","DOI":"10.26574\/maedica.2021.16.1.80"},{"key":"4699_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0091-6749(97)70241-0","volume":"100","author":"M Schatz","year":"1997","unstructured":"Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997;100:301\u20136. https:\/\/doi.org\/10.1016\/s0091-6749(97)70241-0.","journal-title":"J Allergy Clin Immunol"},{"key":"4699_CR6","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.jaci.2021.02.037","volume":"147","author":"CD Chambers","year":"2021","unstructured":"Chambers CD, Krishnan JA, Alba L, Albano JD, Bryant AS, Carver M, et al. The safety of asthma medications during pregnancy and lactation: Clinical management and research priorities. J Allergy Clin Immunol. 2021;147:2009\u201320. https:\/\/doi.org\/10.1016\/j.jaci.2021.02.037.","journal-title":"J Allergy Clin Immunol"},{"key":"4699_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1753465814540029","volume":"8","author":"JA Namazy","year":"2014","unstructured":"Namazy JA, Schatz M. The safety of asthma medications during pregnancy: an update for clinicians. Ther Adv Respir Dis. 2014;8:103\u201310. https:\/\/doi.org\/10.1177\/1753465814540029.","journal-title":"Ther Adv Respir Dis"},{"key":"4699_CR8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1316","volume":"137","author":"NB Gidaya","year":"2016","unstructured":"Gidaya NB, Lee BK, Burstyn I, Michael Y, Newschaffer CJ, Mortensen EL. In utero exposure to \u03b2-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders. Pediatrics. 2016;137:e20151316. https:\/\/doi.org\/10.1542\/peds.2015-1316.","journal-title":"Pediatrics"},{"key":"4699_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/cea.13353","volume":"49","author":"T Gong","year":"2019","unstructured":"Gong T, Lundholm C, Rejn\u00f6 G, B\u00f6lte S, Larsson H, D\u2019Onofrio BM, et al. Parental asthma and risk of autism spectrum disorder in offspring: A population and family-based case-control study. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2019;49:883\u201391. https:\/\/doi.org\/10.1111\/cea.13353.","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"4699_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00787-017-0956-4","volume":"26","author":"H Liang","year":"2017","unstructured":"Liang H, Chen J, Miao M, Christensen J, Dalsgaard S, Yuan W, et al. In utero exposure to \u03b2-2-adrenergic receptor agonist and attention-deficit\/hyperactivity disorder in children. Eur Child Adolesc Psychiatry. 2017;26:847\u201356. https:\/\/doi.org\/10.1007\/s00787-017-0956-4.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"4699_CR11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/pds.4214","volume":"26","author":"X Su","year":"2017","unstructured":"Su X, Yuan W, Chen J, Miao M, Olsen J, Pedersen LH, et al. Prenatal exposure to \u03b22-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring. Pharmacoepidemiol Drug Saf. 2017;26:812\u20138. https:\/\/doi.org\/10.1002\/pds.4214.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4699_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202078","volume":"13","author":"L Li","year":"2018","unstructured":"Li L, Wang Z, Liang H, Yang F, Yuan W, Gelaye B, et al. Risk of childhood cerebral palsy following prenatal exposure to \u00df2-adrenergic receptor agonist: a nationwide cohort study. PLoS One. 2018;13:e0202078. https:\/\/doi.org\/10.1371\/journal.pone.0202078.","journal-title":"PLoS One"},{"key":"4699_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11689-011-9093-4","volume":"3","author":"LA Croen","year":"2011","unstructured":"Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C, Zimmerman AW. Prenatal exposure to \u03b22-adrenergic receptor agonists and risk of autism spectrum disorders. J Neurodev Disord. 2011;3:307\u201315. https:\/\/doi.org\/10.1007\/s11689-011-9093-4.","journal-title":"J Neurodev Disord"},{"key":"4699_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.39347","volume":"6","author":"A Nagata","year":"2023","unstructured":"Nagata A, Masumoto T, Nishigori H, Nakagawa T, Otani S, Kurozawa Y. Neurodevelopmental outcomes among offspring exposed to corticosteroid and B2-adrenergic agonists in utero. JAMA Netw Open. 2023;6:e2339347. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.39347.","journal-title":"JAMA Netw Open"},{"key":"4699_CR15","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1016\/j.jaip.2021.07.055","volume":"9","author":"MP Bokern","year":"2021","unstructured":"Bokern MP, Robijn AL, Jensen ME, Barker D, Callaway L, Clifton V, et al. Factors associated with asthma exacerbations during pregnancy. J Allergy Clin Immunol Pract. 2021;9:4343-4352.e4. https:\/\/doi.org\/10.1016\/j.jaip.2021.07.055.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4699_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/pds.4648","volume":"27","author":"J Chen","year":"2018","unstructured":"Chen J, Liang H, Miao M, Su X, Yang F, Thomsen RW, et al. In utero beta\u20102\u2010adrenergic agonists exposure and risk of epilepsy: a Danish nationwide population\u2010based cohort study. Pharmacoepidemiol Drug Saf. 2018;27:1200\u20138. https:\/\/doi.org\/10.1002\/pds.4648.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"4699_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031197","volume":"9","author":"N Melamed","year":"2019","unstructured":"Melamed N, Asztalos E, Murphy K, Zaltz A, Redelmeier D, Shah BR, et al. Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study. BMJ Open. 2019;9:e031197. https:\/\/doi.org\/10.1136\/bmjopen-2019-031197.","journal-title":"BMJ Open"},{"key":"4699_CR18","doi-asserted-by":"publisher","first-page":"F402","DOI":"10.1136\/adc.2008.150250","volume":"94","author":"OM Peltoniemi","year":"2009","unstructured":"Peltoniemi OM, Kari MA, Lano A, Yliherva A, Puosi R, Lehtonen L, et al. Two-year follow-up of a randomised trial with repeated antenatal betamethasone. Arch Dis Child Fetal Neonatal Ed. 2009;94:F402-406. https:\/\/doi.org\/10.1136\/adc.2008.150250.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"4699_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.tox.2018.03.001","volume":"400","author":"TA Slotkin","year":"2018","unstructured":"Slotkin TA, Skavicus S, Seidler FJ. Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: terbutaline and dexamethasone, separately and together. Toxicology. 2018;400:57\u201364. https:\/\/doi.org\/10.1016\/j.tox.2018.03.001.","journal-title":"Toxicology"},{"key":"4699_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/358608","volume":"2014","author":"R Perna","year":"2014","unstructured":"Perna R, Loughan A, Perkey H, Tyson K. Terbutaline and associated risks for neurodevelopmental disorders. Child Dev Res. 2014;2014:1\u20136. https:\/\/doi.org\/10.1155\/2014\/358608.","journal-title":"Child Dev Res"},{"key":"4699_CR21","unstructured":"WIMD 2014. https:\/\/statswales.gov.wales\/Catalogue\/Community-Safety-and-Social-Inclusion\/Welsh-Index-of-Multiple-Deprivation\/Archive\/WIMD-2014. Accessed 2 Dec 2024."},{"key":"4699_CR22","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781139342834","volume-title":"Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide","author":"JWR Twisk","year":"2013","unstructured":"Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology: A Practical Guide. 2nd edition. Cambridge: Cambridge University Press; 2013. https:\/\/doi.org\/10.1017\/CBO9781139342834.","edition":"2nd edition"},{"key":"4699_CR23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1536867X0700700205","volume":"7","author":"J Cui","year":"2007","unstructured":"Cui J. QIC program and model selection in GEE analyses. The Stata Journal: Promoting communications on statistics and Stata. 2007;7:209\u201320.","journal-title":"The Stata Journal: Promoting communications on statistics and Stata"},{"key":"4699_CR24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajog.2009.07.010","volume":"201","author":"FR Witter","year":"2009","unstructured":"Witter FR, Zimmerman AW, Reichmann JP, Connors SL. In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes. Am J Obstet Gynecol. 2009;201:553\u20139. https:\/\/doi.org\/10.1016\/j.ajog.2009.07.010.","journal-title":"Am J Obstet Gynecol"},{"key":"4699_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1124\/jpet.103.060095","volume":"308","author":"MC Rhodes","year":"2004","unstructured":"Rhodes MC, Seidler FJ, Abdel-Rahman A, Tate CA, Nyska A, Rincavage HL, et al. Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex. J Pharmacol Exp Ther. 2004;308:529\u201337. https:\/\/doi.org\/10.1124\/jpet.103.060095.","journal-title":"J Pharmacol Exp Ther"},{"key":"4699_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-3806(01)00282-6","volume":"131","author":"TA Slotkin","year":"2001","unstructured":"Slotkin TA, Tate CA, Cousins MM, Seidler FJ. \u03b2-adrenoceptor signaling in the developing brain: sensitization or desensitization in response to terbutaline. Dev Brain Res. 2001;131:113\u201325. https:\/\/doi.org\/10.1016\/S0165-3806(01)00282-6.","journal-title":"Dev Brain Res"},{"key":"4699_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.taap.2004.08.005","volume":"203","author":"A Meyer","year":"2005","unstructured":"Meyer A, Seidler FJ, Aldridge JE, Slotkin TA. Developmental exposure to terbutaline alters cell signaling in mature rat brain regions and augments the effects of subsequent neonatal exposure to the organophosphorus insecticide chlorpyrifos. Toxicol Appl Pharmacol. 2005;203:154\u201366. https:\/\/doi.org\/10.1016\/j.taap.2004.08.005.","journal-title":"Toxicol Appl Pharmacol"},{"key":"4699_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bbi.2019.08.198","volume":"82","author":"X Liu","year":"2019","unstructured":"Liu X, Dalsgaard S, Munk-Olsen T, Li J, Wright RJ, Momen NC. Parental asthma occurrence, exacerbations and risk of attention-deficit\/hyperactivity disorder. Brain Behav Immun. 2019;82:302\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2019.08.198.","journal-title":"Brain Behav Immun"},{"key":"4699_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.5152\/TurkArchPediatr.2025.24299","volume":"60","author":"J Uberos","year":"2025","unstructured":"Uberos J, V\u00e9lez-Moreno E, D\u00edaz-Granados I, Fern\u00e1ndez-Mar\u00edn E, Ru\u00edz-L\u00f3pez A, Contreras-Chova F, et al. Perinatal Treatment with Corticosteroids and Its Relation with Neurodevelopment in Premature Newborns: A Systematic Review of the Literature. Turk Arch Pediatr. 2025;60:355\u201361. https:\/\/doi.org\/10.5152\/TurkArchPediatr.2025.24299.","journal-title":"Turk Arch Pediatr"},{"key":"4699_CR30","unstructured":"Asthma | British Thoracic Society | Better lung health for all. https:\/\/www.brit-thoracic.org.uk\/quality-improvement\/guidelines\/asthma\/. Accessed 3 Aug 2024."},{"key":"4699_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050963","volume":"8","author":"AT Langridge","year":"2013","unstructured":"Langridge AT, Glasson EJ, Nassar N, Jacoby P, Pennell C, Hagan R, et al. Maternal conditions and perinatal characteristics associated with autism spectrum disorder and intellectual disability. PLoS One. 2013;8:e50963. https:\/\/doi.org\/10.1371\/journal.pone.0050963.","journal-title":"PLoS One"},{"key":"4699_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156662","volume":"11","author":"Z Zheng","year":"2016","unstructured":"Zheng Z, Zhang L, Zhu T, Huang J, Qu Y, Mu D. Association between asthma and autism spectrum disorder: a meta-analysis. PLoS One. 2016;11:e0156662. https:\/\/doi.org\/10.1371\/journal.pone.0156662.","journal-title":"PLoS One"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04699-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04699-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:08:09Z","timestamp":1774613289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04699-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4699"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04699-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"21 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Information Governance Review Panel and was covered by a Data Sharing Agreement between the SAIL Databank and the University of Glasgow.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}